Pål Johansen
Pål Johansen
Senior scientists, University Hospital Zurich
Verified email at
Cited by
Cited by
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
H Tamber, P Johansen, HP Merkle, B Gander
Advanced drug delivery reviews 57 (3), 357-376, 2005
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial
G Senti, BM Prinz Vavricka, I Erdmann, MI Diaz, R Markus, SJ McCormack, ...
Proceedings of the National Academy of Sciences 105 (46), 17908-17912, 2008
Immunity in response to particulate antigen-delivery systems
T Storni, TM Kündig, G Senti, P Johansen
Advanced drug delivery reviews 57 (3), 333-355, 2005
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
G Senti, R Crameri, D Kuster, P Johansen, JM Martinez-Gomez, N Graf, ...
Journal of Allergy and Clinical Immunology 129 (5), 1290-1296, 2012
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
P Johansen, Y Men, HP Merkle, B Gander
European Journal of Pharmaceutics and Biopharmaceutics 50 (1), 129-146, 2000
Use of A‐type CpG oligodeoxynucleotides as an adjuvant in allergen‐specific immunotherapy in humans: a phase I/IIa clinical trial
G Senti, P Johansen, S Haug, C Bull, C Gottschaller, P Müller, T Pfister, ...
Clinical & Experimental Allergy 39 (4), 562-570, 2009
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
G Senti, N Graf, S Haug, N Rüedi, S von Moos, T Sonderegger, ...
Journal of Allergy and Clinical Immunology 124 (5), 997-1002, 2009
Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression
A Fettelschoss, M Kistowska, S LeibundGut-Landmann, HD Beer, ...
Proceedings of the National Academy of Sciences 108 (44), 18055-18060, 2011
Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems
D Mohanan, B Slütter, M Henriksen-Lacey, W Jiskoot, JA Bouwstra, ...
Journal of Controlled Release 147 (3), 342-349, 2010
Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives
P Johansen, Y Men, R Audran, G Corradin, HP Merkle, B Gander
Pharmaceutical research 15, 1103-1110, 1998
Antigen kinetics determines immune reactivity
P Johansen, T Storni, L Rettig, Z Qiu, A Der-Sarkissian, KA Smith, ...
Proceedings of the National Academy of Sciences 105 (13), 5189-5194, 2008
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
G Senti, S von Moos, F Tay, N Graf, T Sonderegger, P Johansen, ...
Journal of allergy and clinical immunology 129 (1), 128-135, 2012
Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology
S Baenziger, M Heikenwalder, P Johansen, E Schlaepfer, U Hofer, ...
Blood, The Journal of the American Society of Hematology 113 (2), 377-388, 2009
Intralymphatic injections as a new administration route for allergen-specific immunotherapy
JM Martínez-Gómez, P Johansen, I Erdmann, G Senti, R Crameri, ...
International archives of allergy and immunology 150 (1), 59-65, 2009
Technological considerations related to the up-scaling of protein microencapsulation by spray-drying
P Johansen, HP Merkle, B Gander
European Journal of Pharmaceutics and Biopharmaceutics 50 (3), 413-417, 2000
Direct intralymphatic injection of peptide vaccines enhances immunogenicity
P Johansen, AC Häffner, F Koch, K Zepter, I Erdmann, K Maloy, JJ Simard, ...
European journal of immunology 35 (2), 568-574, 2005
A virus-like particle-based vaccine selectively targeting soluble TNF-α protects from arthritis without inducing reactivation of latent tuberculosis
G Spohn, R Guler, P Johansen, I Keller, M Jacobs, M Beck, F Rohner, ...
The Journal of Immunology 178 (11), 7450-7457, 2007
Intralymphatic immunotherapy
G Senti, P Johansen, TM Kündig
Current opinion in allergy and clinical immunology 9 (6), 537-543, 2009
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
G Senti, S von Moos, F Tay, N Graf, P Johansen, TM Kündig
Allergy 70 (6), 707-710, 2015
Thermodynamic approach to protein microencapsulation into poly (D, L-lactide) by spray drying
B Gander, P Johansen, H Nam-Trân, HP Merkle
International Journal of Pharmaceutics 129 (1-2), 51-61, 1996
The system can't perform the operation now. Try again later.
Articles 1–20